Inhibition of allograft and concordant xenograft rejection

作者: Johan Beyers Van Den Bogaerde , David James Graham White

DOI:

关键词: Complement inhibitorCyclosporin aMedicineImmunologyCobra venom factorCancer research

摘要: Cyclosporin A, or another compound having cyclosporin A-like activity, and cobra venom factor, complement inhibitor, can be used in conjunction with each other to promote allograft concordant xenograft survival rescue such grafts from rejection.

参考文章(3)
Hutchins Gm, Baumgartner Wa, Hall Ts, Reitz Ba, Rosengard Br, Borkon Am, Adachi H, Effects of cyclosporine, aspirin, and cobra venom factor on discordant cardiac xenograft survival in rats. Transplantation proceedings. ,vol. 19, pp. 1145- 1148 ,(1987)
David W. Martin, Victor Nussenzweig, Ingrid W. Caras, Michael A. Davitz, Membrane anchor fusion polypeptides ,(1987)
Robert L. Suddith, Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini, Alpha tocopherol-based vesicles ,(1986)